Essa Pharma is a clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment of cancer. With a commitment to advancing targeted treatments, the company primarily works on potent small molecule inhibitors designed to selectively target and inhibit the activity of specific proteins involved in cancer cell growth and survival. Essa Pharma aims to address significant unmet needs in oncology, particularly in the treatment of prostate cancer, by leveraging its expertise in medicinal chemistry and drug development to bring new options to patients. Through its research and development initiatives, the company strives to enhance patient outcomes and improve the quality of life for those affected by cancer. Read More
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
NEW YORK, July 19, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
